Background Image
Table of Contents Table of Contents
Previous Page  6 / 76 Next Page
Show Menu
Previous Page 6 / 76 Next Page
Page Background


2016 Report to Our Donors

Marking 20 years on

University Avenue,

and visualizing the

20 years ahead

November 2015 marked the 20th anniversary of

Princess Margaret Cancer Centre’s move from its

original location on Sherbourne Street to its current

location in the heart of Toronto’s Medical Discovery

District on University Avenue. It was an opportunity to

pay tribute to the progress made in the past 20 years

and open a dialogue about our aspirations and ideas

on how the care of cancer patients will change in the

next 20 years.

A number of esteemed speakers shared their

predictions about the future of cancer research and

healthcare systems in 2035, including Dr. Peter Pisters,

President and CEO of University Health Network, who

described his vision:

Harnessing technology to connect patients and their

healthcare team in efficient ways and managing the

overwhelming amount of data that will be produced

in patient care in the future are major

priorities for our healthcare system.

As part of University Health Network,

The Princess Margaret benefits from

technology development that is

taking place across the organization.

New ‘apps’ that help patients manage

their disease are being readied for

prime time.

As for The Princess Margaret’s

specific vision to Conquer Cancer

in Our Lifetime, we are optimistic.

For example, we are leading in the

application of new tools that allow us

to map the genome of each patient’s

tumor and understand the specific

driver mutations that are fueling

it. The days of treating all patients

with lung cancer or with colon cancer in the same way

are behind us. We are now in the age of Personalized

Cancer Medicine.

Virtually every week, we read something in the

news about the potential of our immune system

to recognize and eradicate cancer. We saw this

opportunity early and have built on historical strength

developed over the past 20 years through additional

recruitment and investment. As we translate our

research discoveries from the laboratory to the clinic,

we are playing an important role on the world stage in

developing and evaluating new approaches to utilize

our own immune system to seek out and target cancer.

We foresee the day when cancer will be treated as a

chronic disease like diabetes is treated today.

“We will facilitate a process where

there will be much more real-time

access to clinical decision support,

to data that’s required to manage

diseases in real time, and where

patients will become partners in

their care in a much different way

than they are engaged now.”